Author
@gmorton512 gmorton512
grade Cx.com/gmorton512 ↗
Disciplined O'Neil-style daily market diagnostician tracking growth-leadership trend health
Publishes a near-daily market diagnosis (uptrend/power-trend
trader score
-0.76
hit rate
40%
mean α
-0.37%
signals 14d
22
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 40% hit rate, -0.37% mean alpha, trader score -0.76. Their last-14d mentions, direction-adjusted, have moved +0.5% since posting (mean over 10 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-07-02 | IWM | @gmorton512 | +0.00 | Market diagnosis says chip growth stocks were whacked while several indexes hit highs in a difficult chop environment. | — | tweet ↗ |
| 2026-07-02 | DIA | @gmorton512 | +0.00 | Market diagnosis says chip growth stocks were whacked while several indexes hit highs in a difficult chop environment. | — | tweet ↗ |
| 2026-07-01 | IWM | @gmorton512 | +0.25 | Author says Nasdaq reclaimed key moving averages and market is trying to resume an uptrend. | -0.6% | tweet ↗ |
| 2026-07-01 | QQQ | @gmorton512 | +0.35 | Author says Nasdaq reclaimed key moving averages and market is trying to resume an uptrend. | -1.7% | tweet ↗ |
| 2026-07-01 | DIA | @gmorton512 | +0.25 | Author says Nasdaq reclaimed key moving averages and market is trying to resume an uptrend. | +1.0% | tweet ↗ |
| 2026-06-30 | XBI | @gmorton512 | +0.25 | Considers INDV and AXGN strong CANSLIM biotech stocks due to triple-digit EPS and sales growth. | +1.4% | tweet ↗ |
| 2026-06-30 | INDV | @gmorton512 | +0.45 | Considers INDV and AXGN strong CANSLIM biotech stocks due to triple-digit EPS and sales growth. | · | tweet ↗ |
| 2026-06-30 | AXGN | @gmorton512 | +0.45 | Considers INDV and AXGN strong CANSLIM biotech stocks due to triple-digit EPS and sales growth. | · | tweet ↗ |
| 2026-06-30 | INDV | @gmorton512 | +0.50 | Calls INDV and AXGN constructive setups amid strength in profitable biotechs/medicals. | · | tweet ↗ |
| 2026-06-30 | AXGN | @gmorton512 | +0.50 | Calls INDV and AXGN constructive setups amid strength in profitable biotechs/medicals. | · | tweet ↗ |
| 2026-06-30 | · | @gmorton512 | · | Daily market diagnosis: uptrend trying to resume but power trend under pressure; advises caution. | · | tweet ↗ |
| 2026-06-29 | LLY | @gmorton512 | +0.20 | Market diagnosis says Nasdaq and S&P under pressure with rotation into biotech/software. | -1.3% | tweet ↗ |
| 2026-06-29 | BE | @gmorton512 | -0.35 | Market diagnosis says Nasdaq and S&P under pressure with rotation into biotech/software. | -1.5% | tweet ↗ |
| 2026-06-27 | · | @gmorton512 | · | IBD 50 table shows rotation from tech/AI leaders to medical and other sectors. | · | tweet ↗ |
| 2026-06-25 | INDV | @gmorton512 | +0.25 | Market rotation out of AI growth; INDV breaking out and MU blowout earnings lift futures. | · | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.